Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Center for Complementary and Alternative Medicine (NCCAM) Office of Dietary Supplements (ODS) |
---|---|
Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
ClinicalTrials.gov Identifier: | NCT00200798 |
There is accumulating evidence from various sources that extracts from the milk thistle plant can be useful in the treatment of a variety of liver ailments as well as other disorders. This investigation will essentially be composed of two individual normal volunteer studies of milk thistle. The first study will assess the rate and extent of absorption of components of a standardized botanical extract obtained from the milk thistle plant. This first study is termed a bioavailability study. This investigation will take approximately 8 weeks and involve 10 clinic visits. Secondly, a drug interaction study will be performed. This is an assessment study of the potential for this botanical extract to interact with other prescription or over-the-counter medications. This study is also expected to take approximately 8 weeks but will involve 18 clinic visits. In both studies all subjects will receive the same milk thistle supplement and no placebo will be administered.
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Pharmacokinetics and Drug Interactions With Milk Thistle |
plasma & urine
Estimated Enrollment: | 32 |
Study Start Date: | May 2006 |
Estimated Study Completion Date: | August 2007 |
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Normal healthy volunteers
Inclusion Criteria:
Exclusion Criteria:
Any of the following conditions are cause for exclusion and/or discontinuation from the study:
Contact: John S. Markowitz, Pharm.D. | 843-792-0172 | markowij@musc.edu |
Contact: Jennifer L. Donovan, Ph.D. | 843-792-5589 | donovanj@musc.edu |
United States, South Carolina | |
Medical University of South Carolina, GCRC | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Sub-Investigator: Jennifer L. Donovan, Ph.D. |
Principal Investigator: | John S. Markowitz, Pharm.D. | Medical University of South Carolina |
Responsible Party: | MUSC ( John S. Markowitz, Pharm.D. ) |
Study ID Numbers: | R21 AT002817-01 |
Study First Received: | September 13, 2005 |
Last Updated: | August 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00200798 |
Health Authority: | United States: Federal Government |
Milk Thistle Silymarin pharmacokinetics drug interactions Normal volunteers |
Silymarin Healthy |